Anebulo Pharmaceuticals Inc. Skyrocketed
Fri, Sep 20, 2024 at 05:32 PM
Anebulo Pharmaceuticals Inc. (ANEB:NASDAQ) rocketted at $3.08, representing a gain of 39.4%. The stock got featured on our News Catalysts scanner on Sun, Sep 08, 2024 at 11:09 PM in the 'EARNINGS' category. From Fri, Sep 06, 2024, the stock recorded 66.67% Up Days and 60.00% Green Days
About Anebulo Pharmaceuticals Inc. (ANEB:NASDAQ)
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company. It is developing novel solutions for people suffering from cannabinoid overdose and substance addiction.
Top 10 Gainers:
- Battalion Oil Corporation (BATL:NYSEMKT), 123.47%
- Banzai International, Inc. Class A Common Stock (BNZI:NASDAQ), 98.26%
- Tempo Automation Holdings Inc. (TMPO:NASDAQ), 84.62%
- JIN MEDICAL INTERNATIONAL LTD. (ZJYL:NASDAQ), 54.55%
- NovaBay Pharmaceuticals, Inc. (NBY:NYSEMKT), 48.92%
- Expion360 Inc. (XPON:NASDAQ), 45.7%
- Anebulo Pharmaceuticals Inc. (ANEB:NASDAQ), 39.37%
- CERo Therapeutics Holdings Inc Com (CERO:NASDAQ), 36.78%
- Alliance Entertainment Holding Corporation (AENT:NASDAQ), 33.82%
- Verb Technology Company, Inc. (VERB:NASDAQ), 33.09%